| Current contact allergens |
3 |
| 2019 ARIA Care pathways for allergen immunotherapy |
2 |
| Allergen immunotherapy with rare allergens: a (public health) review |
1 |
| Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper |
1 |
| Occupational hypersensitivity pneumonitis: an EAACI position paper |
1 |
| Dietary implications: Salicylic acid and ASA-intolerance |
1 |
| Test allergens: Current state of availability from a regulatory point of view |
1 |
| Therapy of aphthous stomatitis with serious consequences - contact-allergic glossitis and contact-allergic stomatitis to propolis |
1 |
| Early life environmental exposure protection or risk for allergic diseases |
1 |
| Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care |
1 |
| Can the severity of N-ERD be predicted by nasal challenge with acetylsalicylic acid? |
1 |
| Endotype-driven care pathways in chronic rhinosinusitis (CRS) |
1 |
| Hereditary angioedema - current and future therapies |
1 |
| Industrial enzymes as cause for occupational airway allergies - a review |
1 |
| The Therapeutic Allergen-Regulation (TAV) and allergen-specific Immunotherapy: what else is it allowed to prescribe? |
1 |
| Allergic contact dermatitis to continuous glucose monitoring systems and insulin patchpumps |
1 |
| Regulation of allergen extracts: Quantification of single allergens |
0 |
| SQ (R) house-dust-mite SLIT-tablet: Overview of the results of the clinical trials in patients with house-dust mite-induced allergic rhinitis and asthma |
0 |
| Skin tests today and in the future: What was, what is, what will be? |
0 |
| Medical treatment options for allergic rhinitis in the German Health Care System |
0 |
| The Current Framework Conditions for the Activity of allergological Practices |
0 |
| Legal aspects of specific immunotherapy (SIT): guideline-directed care - economic performance audit - patient education |
0 |
| Incompatibility and allergic reactions to implanted hearing devices |
0 |
| Autoimmune middle ear disease: a diagnostic chameleon |
0 |
| Eosinophilic otitis media (EOM) |
0 |
| Middle ear diseases in inhalation allergies |
0 |
| Otitis media with effusion in allergic children: a setting for conservative treatment or is surgery mandatory? |
0 |
| Auricle and auditory canal: Allergy or not? |
0 |
| Extrinsic-allergic alveolitis caused by moulds |
0 |
| Detection of mould fungi in indoor areas |
0 |
| Moulds and indoor asthma |
0 |
| AWMF Guideline Medical clinical diagnostics of indoor mould exposure |
0 |
| An overview of occupational allergy to fish and shellfish: Towards improved management of seafood processing workers |
0 |
| Molecular allergy diagnosis - where are we now with regard to occupational allergies? |
0 |
| Occupational hymenoptera venom allergy - might get expensive! |
0 |
| Angioedema in childhood - Tricks and tipps for management in praxis |
0 |
| Recurrent angioedema - how to measure and control disease activity during therapy? |
0 |
| Aquired bradykinin-mediated angioedema - which causes are involved? |
0 |
| Mast cell-mediated angioedema - current and future therapies |
0 |
| New guidelines for urticaria and hereditary angioedema - what changes? what remains the same? |
0 |
| Recurrent angioedema - Questions to identify the cause |
0 |
| Anti-IgE for treatment of Polyposis nasi |
0 |
| N-ERD: a short review with scope on aspirin desenzitization |
0 |
| Impact of sinonasal epithelium on chronic rhinosinusitis |
0 |
| Wheat sensitivity without the presence of celiac disease or wheat allergy |
0 |
| Histamine intolerance: Causes, diagnosis and therapy |
0 |
| Importance of carbohydrates in diagnosis and therapy of food intolerance |
0 |
| Rare Food Allergy Elicitors: back on track with IgE |
0 |
| Eosinophilic Esophagitis - an allergic disease? |
0 |
| Role of dietary interventions in food-related abdominal symptoms |
0 |
